GPX4 and neoplasm: Western blot analysis showed that sh-circASH1L accelerated the cisplatin-induced reduction of GPX4 and SLC7A11 expression, as well as the downregulation of CDCA7 and RRM2 in tumor tissues (Figure 8G).